Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Gut microbiota and health, Clostridium difficile and Clostridium perfringens research, Inflammatory Bowel Disease, and Diet and metabolism studies.
A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.
The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis
The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis.
Gut Microbiome Integration in Drug Discovery and Development of Small Molecules.
Longitudinal exposure to antiseizure medications shape gut-derived microbiome, resistome, and metabolome landscape.
Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis.
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses.
Occurrence of Neonatal Necrotizing Enterocolitis in Premature Neonates and Gut Microbiota: A Case-Control Prospective Multicenter Study.
Effects of a <i>Lacticaseibacillus</i> Mix on Behavioural, Biochemical, and Gut Microbial Outcomes of Male Mice following Chronic Restraint Stress.
Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response.
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Very Preterm Children Gut Microbiota Comparison at the Neonatal Period of 1 Month and 3.5 Years of Life.
Gut Microbiota Diversity of Preterm Neonates Is Associated With <i>Clostridioides Difficile</i> Colonization.
Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis.
High engraftment capacity of frozen ready-to-use human fecal microbiota transplants assessed in germ-free mice.
Parasites and diet as main drivers of the Malagasy gut microbiome richness and function.
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
Assessment of Neonatal Intensive Care Unit Practices and Preterm Newborn Gut Microbiota and 2-Year Neurodevelopmental Outcomes.
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening.
Late weaning is associated with increased microbial diversity and Faecalibacterium prausnitzii abundance in the fecal microbiota of piglets.
Gut bacteria are critical for optimal muscle function: a potential link with glucose homeostasis.
Multi-hit early life adversity affects gut microbiota, brain and behavior in a sex-dependent manner.
A Guide for Ex Vivo Handling and Storage of Stool Samples Intended for Fecal Microbiota Transplantation.
Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.
Dietary Protein Intake Level Modulates Mucosal Healing and Mucosa-Adherent Microbiota in Mouse Model of Colitis.
<i>Porphyromonas</i>, a potential predictive biomarker of <i>Pseudomonas aeruginosa</i> pulmonary infection in cystic fibrosis.
The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism
Microbial ecology perturbation in human IgA deficiency
Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice